Now I have sufficient calibration. Let me verify a few more critic claims before finalizing.## Summary
The paper proposes **DIST**, a plug-in inference-time corrective sampler for 3D molecular diffusion models. It formalizes the "dense-concentrated" (DC) structure of molecular distributions, argues this structure makes reverse updates overshoot narrow peaks, and introduces a procedure that batches/perturbs intermediate samples, runs a pilot reverse-inference per batch, and filters batches by a pilot score before continuing. Experiments on QM9 and GEOM-Drugs with three backbones (EDM, GeoLDM, RADM) show consistent stability/validity improvements while reportedly halving the number of reverse steps.

## Strengths
- **Consistent gains across heterogeneous backbones (Table 2).** DIST improves every metric on EDM, GeoLDM, and RADM on both QM9 and GEOM-Drugs — e.g., EDM molecule stability rises 82.0 → 89.9 on QM9 and validity 92.6 → 96.0 on GEOM-Drugs — demonstrating that the plug-in works across GNN/Transformer, equivariant/non-equivariant, regular- and latent-space models.
- **Useful diagnostic experiment (Table 1).** Sweeping the starting timestep from t=0 to t=1000 cleanly demonstrates monotonic degradation (mol stability 95.2 → 82.0), giving direct empirical support for the "intermediate errors accumulate" motivation.
- **Headline efficiency claim is concretely operationalized (Table 3).** Rather than relying on hand-waving, the paper reports per-accepted-molecule timestep counts (413–636 vs. 1000) tied to the actual generation experiments.
- **Ablation on pilot subset size (Table 4)** shows the procedure is reasonably robust to that knob (mol stability 89.5 → 90.5 across sizes 30–100), supporting practicality under budget constraints.

## Weaknesses

### Fatal
None — the empirical contribution stands on its own; the concerns below are about evidence isolation and presentation, not validity of the reported numbers.

### Major
- **The pilot score s_j — the actual filtering signal — is not specified in the main text.** Section 3.2 / "Corrective Sampling" only lists examples ("e.g., round-trip residual, self-consistency, ensemble variance, or chemistry-based penalty"), and these alternatives correspond to fundamentally different methods. If s_j is a chemistry-based penalty, DIST is filtering by a proxy of the very validity metrics reported in Table 2; if it is self-consistency or ensemble variance, the method is doing something substantively different. The interpretation of the headline gains depends entirely on this choice, and the main text should commit to one rule, justify it, and ablate against alternatives. (The appendix likely fixes the implementation, but the central knob still being abstract in the main paper limits how the contribution should be read.)
- **Missing the most natural baseline: best-of-N filtering at t=0 using the same scoring rule.** DIST is operationally a rejection scheme; the comparator that distinguishes "intermediate correction matters" from "filtering by a quality score moves the bar" is to run the base model for N independent trajectories, score them at t=0 by the same s_j, and report survivors. Without this comparator, the paper cannot attribute improvements to the *intermediate* correction mechanism it claims as its novelty.
- **The theory does not actually invoke the DC-structure.** Section 3.1 builds Definition 3.1 with σ_*, Δ, K_0 etc., and Eqs. (6)–(7) give an intuitive overshoot argument. However, Corollary 3.1 is the standard TV data-processing inequality (true for any kernel and any p_t, q_t), and Proposition 3.1 bounds TV by a generic function of coverage and conditional discrepancies — neither σ_* nor Δ nor the overshoot inequality appears in the stated bounds. So the framing "DC-structure causes drift and DIST fixes it" is supported by intuition (Eq. 7), not by the formal results. The theoretical machinery should either be reframed as motivation, or Proposition 3.1 should explicitly carry σ_*/Δ-dependent terms.

### Minor
- **"We are the first to highlight that molecular distributions are highly concentrated and dense" (Sec. 1, contributions) is overreach.** The introduction itself cites Choi et al. 2025; Bohde et al. 2025; Reymond et al. 2012; Martin & Cao 2015 for essentially this observation. Soften to "first to formalize and exploit operationally."
- **Procedural ambiguity at termination.** Section 3.2 says the pilot subset is run to t=0 to compute s_j and surviving batches "concentrate the reverse trajectories around valid molecular peaks," but does not state whether pilot outputs are kept as final samples or discarded while the remainder of each batch is rerun. This affects both reproducibility and the cost accounting in Section 4.3.
- **GEOM-Drugs results lack the standard deviations reported for QM9 (Table 2).** Given the size of the gains (e.g., 92.6 → 96.0 validity for EDM), reporting variance on equal footing would strengthen the claim.
- **Definition 3.1 contains an unused clause.** The "for each k there exists ℓ ≠ k with ‖m_k − m_ℓ‖ ≤ O(Δ)" denseness condition does not appear in the subsequent overshoot derivation (Eqs. 6–7), which uses only σ_* and Δ. Either tighten the definition or show where denseness is load-bearing.
- **Ablation does not vary the scoring rule.** Table 4 varies only the pilot subset size; given the centrality of s_j, an ablation that swaps the scoring rule (chemistry vs. self-consistency vs. ensemble variance) would directly address the largest interpretive uncertainty in the paper.
- **At pilot size = 100 = batch size 100, "pilot subset" collapses to "all candidates."** Worth stating in the table caption so the reader can interpret that row correctly.

### Trivial
- Equation 9 displays π̂_j in the sum but defines π̃_j as the normalized form; reads as a small notation inconsistency.

## Nice-to-Haves
- A side-by-side comparison with at least one prior corrective sampler (e.g., the Cao et al. 2023 line the paper itself cites in Sec. 2.2 / Sec. 3.1) within Table 2 would position DIST among alternative corrective methods rather than only against base diffusion baselines.
- An end-to-end pseudocode block — including what happens to pilot outputs — would close the procedural ambiguity.
- A coverage/accept-rate column alongside Table 3's amortized step counts would make the cost-quality trade-off concrete.

## Removed Points
*These points are flagged to be removed; treat them with caution.*
- *Strength: "Provable error bound for corrective sampling" (Proposition 3.1 + Corollary 3.1)* — Removed as a strength because, on inspection, the bound does not depend on the DC-structure machinery and Corollary 3.1 is a generic TV-contraction (the harsh critique here is correct). The weakness about theory–method disconnect wins over this strength.
- *Critique: "Hyperparameters (t, |B|, τ, perturbation magnitude) are in the appendix, not main paper."* — Demoted/removed under the rule about appendix-deferred details and reproducibility nitpicks; the appendix is stripped by the parser.
- *Critique: "Substantial inference efficiency improvement may not be apples-to-apples because baselines do no candidate selection."* — Partially valid in spirit but largely answered: the paper does report the amortized per-accepted-molecule cost, and the baselines are the standard 1000-step schedules used in their original papers. Keeping it visible only as the Nice-to-Have asking for accept-rate columns.

## Novel Insights
None beyond the paper's own contributions. The genuinely interesting framing — that molecular distributions are pathologically narrow relative to image distributions, making reverse updates prone to overshoot thin peaks — is the paper's own central observation. The follow-up implication (that intermediate, rather than only terminal, correction matters) is original to the paper, though the present evidence does not isolate it from end-state filtering.

## Suggestions
- Commit to a specific pilot score in the main text, write out its computation, and ablate the choice against at least two alternatives.
- Add a best-of-N baseline at t=0 using the same scoring rule, to isolate "intermediate correction matters" from "validity filtering helps."
- Reframe Section 3.1 / 3.2 either by (a) deriving a Proposition 3.1 variant whose right-hand side contains σ_* and Δ, or (b) explicitly labelling the theoretical section as motivation rather than guarantee.
- Report standard deviations for GEOM-Drugs on the same footing as QM9.
- Add end-to-end pseudocode that clarifies the fate of pilot outputs after thresholding, and report accept rates alongside Table 3's amortized step counts.

---

### Evaluation on requested axes
- **Originality:** Moderate. The DC-structure framing is a clean re-articulation of a known observation; the corrective-sampling procedure is a sensible operationalization, but is closely related to existing rejection / guidance schemes for diffusion.
- **Importance:** Moderate. 3D molecular generation under diffusion is an active subfield; a model-agnostic plug-in that lifts validity/stability is genuinely useful.
- **Support for claims:** Mixed. Empirical claims are well-supported in aggregate. The "intermediate correction is what helps" claim is not isolated from validity-style end-state filtering. The theoretical claim "we prove DIST works because of DC-structure" is overstated relative to what the bounds actually carry.
- **Soundness of experiments:** Solid setup (official weights, three backbones, two datasets), modest variance reporting gap on GEOM-Drugs, and the central comparator (best-of-N) is missing.
- **Clarity:** Mostly clear in narrative; Section 3.2 leaves the pilot score abstract, which costs the reader interpretive ground.
- **Value to community:** Real, especially if the pilot-score specification and the missing baseline are addressed.

---

### Calibration Trace

**Anchors retrieved (Round 1, topic = 3D molecular diffusion / corrective sampling):**
- `kKXIYUi8ff.md` — DynamicsDiffusion (avg 3.00, Reject). Weak anchor; this paper is well above it.
- `ItPYVON0mI.md` — CG potentials with energy landscape modulation (avg 3.00, Reject). Weak anchor; well below this paper.
- `mYo9r0CwUf.md` — Volumetric rendering with NeDDF (avg 2.33, Reject). Off-topic weak anchor.
- `G536mmC2HL.md` — TorSeq torsion sequential modeling (avg 3.00, Reject). Below this paper.
- `rwmWd2rjP1.md` — MoreRed: molecule relaxation by reverse diffusion (avg 4.75, Reject). Read in full. Borderline-weak — paper at hand is empirically stronger and broader (three backbones, two datasets, gains across all).
- `JZgqoOu4Ml.md` — Diffusion priors for Bayesian 3D reconstruction (avg 4.00, Reject). Mid-low.
- `jZPqf2G9Sw.md` — Dynamics-Informed Protein Design (avg 5.50, Accept). Comparable in style but more focused.
- `rEEjYlzXUD.md` — Committor functions via deep adaptive sampling (avg 4.25, Reject).
- `NSVtmmzeRB.md` — GeoBFN (avg 8.00, Accept). Strong anchor; clearly above this paper in scope and clarity.
- `uKZdlihDDn.md` — Diffusion Graph Networks for fluid sims (avg 7.60, Accept). Strong, off-topic.
- `zMPHKOmQNb.md` — Walk-Jump Sampling (avg 8.00, Accept). Strong anchor.
- `fV0t65OBUu.md` — Optimal Covariance Matching for diffusion (avg 8.00, Accept). Strong anchor; theory + sampling improvements, cleaner story.

**Round-1 bracket:** Between MoreRed (4.75, Reject) and GeoBFN (8.00, Accept). The paper sits clearly above MoreRed (broader, stronger empirical) but well below GeoBFN (less ambitious, theory–method disconnect). Plausible range: **5 to 6.5**.

**Anchors retrieved (Round 2):**
- `KqbCvIFBY7.md` — Particle Guidance (avg 6.00, Accept). Read in full. Closest stylistic match: plug-in inference-time modification to diffusion sampling with a theoretical analysis and a molecular application. Reviewers credited the clean theoretical exposition; novelty critique was mild. The paper at hand has stronger benchmark gains but a weaker theory–claim coupling and a missing best-of-N comparator.
- `UYZRaUCLAg.md` — Inverse problems in protein space (avg 5.33, Reject).
- `vxBvr5ZpIu.md` — Diffusion-PINN Sampler (avg 5.50, Reject). Borderline split.
- `uNomADvF3s.md` — Lift Your Molecules (avg 6.50, Accept). Read in full. Solid empirical 3D-molecular-generation paper with novel framework; cleaner contribution than this paper.
- `9UoBuhVNh6.md` — Megalodon co-design (avg 6.33, Reject).
- `kzGuiRXZrQ.md` — EQGAT-diff design space (avg 5.75, Accept).
- `5YLsnsjgeC.md` — VFDiff target-aware (avg 6.00, Reject).

**Round-2 narrowing:** The paper is best compared to Particle Guidance (6.00, Accept) and Diffusion-PINN Sampler (5.50, Reject). It is empirically richer than Diffusion-PINN but has methodological clarity issues (pilot score, theory–method gap, missing best-of-N) that Particle Guidance does not. It sits slightly below Particle Guidance.

**Final position:** Just below 6.00 — comparable in scope and benchmark strength but with two real evidence-isolation problems (pilot score underspecification in main text; missing t=0 best-of-N comparator) that would normally require a rebuttal pass before crossing the accept line. Score **5.5**, borderline reject.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>